Ambeed.cn

首页 / / / JNK / IQ-3

IQ-3 {[allProObj[0].p_purity_real_show]}

货号:A696148

IQ-3是一种选择性的JNK3抑制剂,Kd为66 nM。

IQ-3 化学结构 CAS号:312538-03-7
IQ-3 化学结构
CAS号:312538-03-7
IQ-3 3D分子结构
CAS号:312538-03-7
IQ-3 化学结构 CAS号:312538-03-7
IQ-3 3D分子结构 CAS号:312538-03-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

IQ-3 纯度/质量文件 产品仅供科研

货号:A696148 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]
Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]
Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]
更多 >
产品名称 JNK JNK1 JNK2 JNK3 其他靶点 纯度
Mulberroside A 99%+
Loureirin B Calcium Channel,Potassium Channel 99%+
Ginsenoside Re NF-κB 98%
(+)-(3R,8S)-Falcarindiol STAT,ERK 99%+
trans-Zeatin p38 MAPK,ERK 95+%
Urolithin B ERK,NF-κB 95%
Cucurbitacin IIb NF-κB 99%
Astragaloside IV Akt,mTOR,NF-κB 98%
NDMC101 99%+
DB07268 ++++

JNK1, IC50: 9 nM

99%+
SP600125 +

MKK4, IC50: 0.4 μM

+++

JNK1, IC50: 40 nM

+++

JNK2, IC50: 40 nM

+++

JNK3, IC50: 90 nM

98%
JNK-IN-7 ++++

JNK1, IC50: 1.5 nM

++++

JNK2, IC50: 2 nM

++++

JNK3, IC50: 0.7 nM

99%
JNK-IN-8 ++++

JNK1, IC50: 4.7 nM

+++

JNK2, IC50: 18.7 nM

++++

JNK3, IC50: 1 nM

99%+
3,3',5-Triiodo-L-thyronine ++

JNK1, Kd: 240 nM

++

JNK2, Kd: 290 nM

+++

JNK3, Kd: 66 nM

98%
IQ-1S free acid +

JNK1, IC50: 390 nM

++

JNK2, IC50: 360 nM

+++

JNK3, IC50: 87 nM

99%
BI-78D3 ++

JNK, IC50: 280 nM

++

JNK, IC50: 280 nM

++

JNK, IC50: 280 nM

++

JNK, IC50: 280 nM

99%+
Bentamapimod +++

JNK1, IC50: 80 nM

+++

JNK2, IC50: 90 nM

++

JNK3, IC50: 230 nM

98%
Resveratrol +

JNK1, IC50: 50 μM

98%
Indirubin-3′-oxime 99%+
SU3327 +

JNK, IC50: 0.7 μM

+

JNK, IC50: 0.7 μM

+

JNK, IC50: 0.7 μM

+

JNK, IC50: 0.7 μM

99%+
JNK Inhibitor VIII ++++

JNK1, Ki: 2 nM

JNK1, IC50: 45 nM

++++

JNK2, IC50: 160 nM

JNK2, Ki: 4 nM

+++

JNK3, Ki: 52 nM

98%
Doramapimod 99%+
RPI-1 99%
TCS JNK 5a ++

JNK2, pIC50: 6.5

++

JNK3, pIC50: 6.7

98%
SP 600125, negative control +

JNK2, IC50: 18 μM

+

JNK3, IC50: 24 μM

97%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

IQ-3 生物活性

描述 IQ-3 is a specific inhibitor of the JNK family and is particularly potent against JNK3.The Kd values of IQ-3 against JNK1, JNK2 and JNK3 were 0.24 μM, 0.29 μM and 0.066 μM, respectively. Further studies have confirmed that IQ-3 is a competitive inhibitor of the ATP-binding site of JNK3. The IC50 values of the response of IQ-3 to the different analyses in different cells were 2.5 μM and 2.5 μM, respectively. The response IC50 values of IQ-3 in different cells with different analytical methods were 2.2 μM (TNF-α in human monoMac-6 cells), 1.5 μM (IL-6 in human monoMac-6 cells), 4.7 μM (TNF-α in human PBMCs), 9.1 μM (IL-6 in human PBMCs), and 6.1 μM (NO in murine J774.A1), respectively. IQ-3 inhibited LPS-induced NF-κB/AP-1 transcriptional activity with an IC50 value of 1.4 μM (human THP-1 blue monocytes)[1].

IQ-3 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00796302 Attention Deficit Disorder Wit... 展开 >>h Hyperactivity 收起 << Phase 4 Completed - United States, New York ... 展开 >> State University of New York Stony Brook Stony Brook, New York, United States, 11794 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Ohio State University Nisonger Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 收起 <<
NCT00447902 HIV Infections Phase 3 Terminated - United States, California ... 展开 >> 1182.99.32 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States United States, Florida 1182.99.31 Boehringer Ingelheim Investigational Site Fort Lauderdale, Florida, United States United States, Rhode Island 1182.99.12 Boehringer Ingelheim Investigational Site Providence, Rhode Island, United States United States, Texas 1182.99.1 Boehringer Ingelheim Investigational Site Austin, Texas, United States 1182.99.4 Boehringer Ingelheim Investigational Site Houston, Texas, United States Argentina 1182.99.54001 Capital Federal, Argentina Brazil 1182.99.55002 Hospital DIA Sacomã - São Paulo, Brazil 1182.99.55004 Unidade de Referência em doenças Infecciosas Preveníveis Santo André, Brazil 1182.99.55001 Universidade Federal de Sao Paulo Sao Paulo, Brazil 1182.99.55003 Centro de Referência e Treinamento - DST/AIDS Vila Mariana - Sao Paulo, Brazil France 1182.99.3301A Boehringer Ingelheim Investigational Site Garches, France 1182.99.3306G Boehringer Ingelheim Investigational Site Nantes, France 1182.99.3306K Boehringer Ingelheim Investigational Site Nantes, France 1182.99.3310C Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310D Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310E Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310F Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310G Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310H Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3304A Boehringer Ingelheim Investigational Site Paris, France 1182.99.3304C Boehringer Ingelheim Investigational Site Paris, France 1182.99.3302A Boehringer Ingelheim Investigational Site Perpignan, France Germany 1182.99.4909 Boehringer Ingelheim Investigational Site Düsseldorf, Germany Italy 1182.99.3912 Boehringer Ingelheim Investigational Site Ancona, Italy 1182.99.3901 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3911 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3916 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3906 Boehringer Ingelheim Investigational Site Pavia, Italy Spain 1182.99.3402 Barcelona, Spain 1182.99.3407 Madrid, Spain 收起 <<
NCT00796302 - Completed - -

IQ-3 参考文献

[1]Igor A Schepetkin, et al. Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors. Mol Pharmacol. 2012 Jun;81(6):832-45.

IQ-3 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.93mL

0.59mL

0.29mL

14.65mL

2.93mL

1.46mL

29.30mL

5.86mL

2.93mL

IQ-3 技术信息

CAS号312538-03-7
分子式C20H11N3O3
分子量 341.32
别名
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,2-8°C

溶解度

DMSO: 25 mg/mL(73.25 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。